Cerebral infarction
Conditions
Sponsors
The First Affiliated Hospital of Henan University of Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All hospitalized patients with the first diagnosis of cerebral infarction.
Exclusion criteria
Exclusion criteria: 1. Patients with severe liver damage, including patients with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) >= more than 2 times the upper limit of normal value, and AST/ALT>1; 2. Patients with severe renal impairment and patients with serum creatinine >= 3 times the normal value; 3. Patients with secondary cerebral embolism caused by tumors, brain trauma, brain parasites, rheumatic heart disease, atrial fibrillation; 4. Patients with multiple organ failure; 5. Inpatients using XST for less than 5 days or continuous medication for more than 15 days; 6. Use inpatients with too large or too small dose of XST; 7. XST is used in the Chinese medicine hospital, but it is an inpatient with non-blood stasis syndrome; 8. There is no relevant description of the treatment effect of cerebral infarction in the medical record; 9. XST used for treatment is not manufactured by Guangxi Wuzhou Pharmaceutical (Group) Co., Ltd.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptoms;clinical signs;TCM syndrome score;NIHSS score;endpoint efficacy index; | — |
Countries
China
Contacts
Public ContactLi Xuelin
The First Affiliated Hospital of Henan University of Chinese Medicine
Outcome results
None listed